Peggy Thompson is the founder of Plexium. Plexium has raised $165M in total funding. Latest round: Series B. Based in San Diego, California.
Peggy Thompson, Ph.D., is the Senior Vice President of Biology at Plexium, where she leads targeted protein degradation drug discovery efforts. She has over 20 years of experience in drug discovery and development, having previously co-founded eFFECTOR Therapeutics.
Full founder directory · Investor directory · Company funding database · Fundraising library